Duration of postviral airway hyperresponsiveness in children with asthma: effect of atopy.

Paraskevi Xepapadaki, Nikolaos G Papadopoulos, Apostolos Bossios, Emmanuel Manoussakis, Theodoros Manousakas, Photini Saxoni-Papageorgiou
Author Information
  1. Paraskevi Xepapadaki: Allergy Unit, 2nd Pediatric Clinic, University of Athens.

Abstract

BACKGROUND: Respiratory viruses induce asthma exacerbations and airway hyperresponsiveness (AHR). Atopy is an important risk factor for asthma persistence.
OBJECTIVE: We sought to evaluate whether atopy is a risk factor for prolonged AHR after upper respiratory tract infections (URIs).
METHODS: Twenty-five children (13 atopic and 12 nonatopic children) with intermittent virus-induced asthma were studied. Clinical evaluation, skin prick tests, methacholine bronchoprovocation, questionnaires, and a nasal wash specimen were obtained at baseline. For 9 months, subjects completed diary cards with respiratory symptoms. During their first reported cold, a nasal wash specimen was obtained. Methacholine provocation was performed 10 days and 5, 7, 9, and 11 weeks later. In case a new cold developed, the provocation schedule was followed from the beginning.
RESULTS: Viruses were detected in 17 (68%) of 25 patients during their first cold, with rhinovirus being most commonly identified (82%). AHR increased significantly 10 days after the URI, equally in both groups (P = .67), and remained so up to the fifth week. Duration of AHR in subjects experiencing a single URI ranged from 5 to 11 weeks, without a significant difference between groups. In the duration of the study, atopic children experienced more colds and asthma exacerbations than nonatopic children. Thus for duration of AHR, significant prolongation was noted in the atopic group when assessed cumulatively.
CONCLUSION: In asthmatic children the duration of AHR after a single natural cold is 5 to 11 weeks. However, an increased rate of symptomatic cold and asthma episodes in atopic children is associated with considerable cumulative prolongation of AHR, which might help explain the role of atopy as a risk factor for asthma persistence.

References

  1. Thorax. 2002 Apr;57(4):328-32 [PMID: 11923551]
  2. Curr Opin Allergy Clin Immunol. 2003 Feb;3(1):39-44 [PMID: 12582313]
  3. Am J Respir Crit Care Med. 2003 Nov 1;168(9):1091-4 [PMID: 12928311]
  4. Clin Exp Allergy. 1993 Nov;23(11):949-56 [PMID: 10779283]
  5. Allergy. 1989;44(s10):11-59 [PMID: 2683837]
  6. Clin Chest Med. 2001 Dec;22(4):651-9 [PMID: 11787657]
  7. J Allergy Clin Immunol. 2000 Nov;106(5):829-31 [PMID: 11080702]
  8. J Allergy Clin Immunol. 2003 Feb;111(2):215-25; quiz 226 [PMID: 12589337]
  9. BMJ. 1995 May 13;310(6989):1225-9 [PMID: 7767192]
  10. Curr Allergy Asthma Rep. 2003 Mar;3(2):166-71 [PMID: 12562557]
  11. J Med Virol. 1999 May;58(1):100-4 [PMID: 10223554]
  12. Am J Respir Crit Care Med. 1995 Nov;152(5 Pt 1):1490-6 [PMID: 7582282]
  13. Am J Respir Crit Care Med. 1997 Mar;155(3):833-8 [PMID: 9117013]
  14. Pediatr Allergy Immunol. 1998 May;9(2):56-60 [PMID: 9677599]
  15. J Clin Invest. 2002 Jul;110(2):165-75 [PMID: 12122108]
  16. J Allergy Clin Immunol. 2000 Apr;105(4):692-8 [PMID: 10756217]
  17. Allergy. 2003 Sep;58(9):864-7 [PMID: 12911413]
  18. Am J Respir Crit Care Med. 2000 Sep;162(3 Pt 2):S118-23 [PMID: 10988165]
  19. Am J Respir Crit Care Med. 1998 Jun;157(6 Pt 1):1708-20 [PMID: 9620896]
  20. Am J Respir Crit Care Med. 1999 Jul;160(1):100-8 [PMID: 10390386]
  21. Lancet. 2002 Mar 9;359(9309):831-4 [PMID: 11897281]
  22. J Allergy Clin Immunol. 2001 Apr;107(4):586-91 [PMID: 11295643]
  23. Am J Respir Crit Care Med. 2000 Jan;161(1):309-29 [PMID: 10619836]
  24. J Allergy Clin Immunol. 2001 May;107(5 Suppl):S449-55 [PMID: 11344374]
  25. Curr Opin Allergy Clin Immunol. 2005 Apr;5(2):153-9 [PMID: 15764906]
  26. Am J Respir Crit Care Med. 1995 May;151(5):1666-73; discussion 1673-4 [PMID: 7735631]
  27. Clin Exp Allergy. 1996 Jun;26(6):665-76 [PMID: 8809424]
  28. Am J Respir Crit Care Med. 2001 Jun;163(7):1514-5 [PMID: 11401862]
  29. Pediatr Allergy Immunol. 2001 Aug;12(4):181-7 [PMID: 11555314]
  30. Am J Respir Crit Care Med. 2000 Jul;162(1):50-6 [PMID: 10903219]
  31. J Clin Invest. 1994 Dec;94(6):2200-8 [PMID: 7989575]
  32. Am J Respir Crit Care Med. 2002 May 1;165(9):1285-9 [PMID: 11991880]
  33. Am Rev Respir Dis. 1976 Feb;113(2):131-9 [PMID: 1247226]
  34. J Allergy Clin Immunol. 2000 May;105(5):889-91 [PMID: 10808166]
  35. Curr Allergy Asthma Rep. 2004 Mar;4(2):159-65 [PMID: 14769266]
  36. BMJ. 2002 Mar 30;324(7340):763 [PMID: 11923159]
  37. Am J Respir Crit Care Med. 2003 Feb 1;167(3):371-8 [PMID: 12554625]
  38. Am J Respir Crit Care Med. 1996 Sep;154(3 Pt 1):661-4 [PMID: 8810602]
  39. Eur Respir J. 1996 Nov;9(11):2250-5 [PMID: 8947068]
  40. Am J Respir Crit Care Med. 2003 Nov 15;168(10):1174-80 [PMID: 12893645]
  41. J Allergy Clin Immunol. 1999 Oct;104(4 Pt 1):775-85 [PMID: 10518821]
  42. J Clin Invest. 1989 Jan;83(1):1-10 [PMID: 2536042]
  43. J Immunol. 2000 Jun 15;164(12):6583-92 [PMID: 10843718]
  44. J Infect Dis. 2004 May 15;189(10):1856-65 [PMID: 15122522]
  45. J Virol Methods. 1999 Jul;80(2):179-85 [PMID: 10471027]
  46. Clin Exp Allergy. 1997 Jan;27(1):36-45 [PMID: 9117878]
  47. Am J Respir Crit Care Med. 1995 Sep;152(3):1107-36 [PMID: 7663792]
  48. Clin Exp Allergy. 2002 Apr;32(4):537-42 [PMID: 11972599]
  49. Am J Respir Crit Care Med. 2001 Dec 1;164(11):2107-13 [PMID: 11739143]
  50. Am J Respir Crit Care Med. 1997 Jun;155(6):1872-6 [PMID: 9196088]
  51. J Exp Med. 2005 Mar 21;201(6):937-47 [PMID: 15781584]
  52. Eur Respir J. 2002 Feb;19(2):341-9 [PMID: 11866016]

MeSH Term

Asthma
Bronchial Hyperreactivity
Case-Control Studies
Child
Common Cold
Female
Humans
Hypersensitivity
Male
Polymerase Chain Reaction
Prospective Studies
Respiratory Tract Infections
Time Factors
Virus Diseases
Viruses

Word Cloud

Created with Highcharts 10.0.0AHRchildrenasthmacoldatopicriskfactoratopy511weeksdurationexacerbationsairwayhyperresponsivenesspersistencerespiratorynonatopicnasalwashspecimenobtained9subjectsfirstprovocation10daysincreasedURIgroupsDurationsinglesignificantprolongationBACKGROUND:RespiratoryvirusesinduceAtopyimportantOBJECTIVE:soughtevaluatewhetherprolongeduppertractinfectionsURIsMETHODS:Twenty-five1312intermittentvirus-inducedstudiedClinicalevaluationskinpricktestsmethacholinebronchoprovocationquestionnairesbaselinemonthscompleteddiarycardssymptomsreportedMethacholineperformed7latercasenewdevelopedschedulefollowedbeginningRESULTS:Virusesdetected1768%25patientsrhinoviruscommonlyidentified82%significantlyequallyP=67remainedfifthweekexperiencingrangedwithoutdifferencestudyexperiencedcoldsThusnotedgroupassessedcumulativelyCONCLUSION:asthmaticnaturalHoweverratesymptomaticepisodesassociatedconsiderablecumulativemighthelpexplainrolepostviralasthma:effect

Similar Articles

Cited By